Compare UBFO & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UBFO | RPID |
|---|---|---|
| Founded | 1987 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 177.0M | 178.6M |
| IPO Year | N/A | 2021 |
| Metric | UBFO | RPID |
|---|---|---|
| Price | $10.03 | $3.13 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 61.0K | ★ 162.2K |
| Earning Date | 01-26-2026 | 02-27-2026 |
| Dividend Yield | ★ 4.72% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.65 | N/A |
| Revenue | ★ $46,495,000.00 | $30,523,000.00 |
| Revenue This Year | N/A | $19.36 |
| Revenue Next Year | N/A | $21.48 |
| P/E Ratio | $15.63 | ★ N/A |
| Revenue Growth | N/A | ★ 16.63 |
| 52 Week Low | $7.32 | $1.00 |
| 52 Week High | $10.53 | $4.50 |
| Indicator | UBFO | RPID |
|---|---|---|
| Relative Strength Index (RSI) | 49.66 | 42.57 |
| Support Level | $9.96 | $2.70 |
| Resistance Level | $10.21 | $3.45 |
| Average True Range (ATR) | 0.18 | 0.23 |
| MACD | -0.04 | 0.03 |
| Stochastic Oscillator | 34.85 | 47.56 |
United Security Bancshares operates as the holding for United Security Bank. It provides commercial banking services to the business and professional community, and individuals located in Fresno, Madera, Santa Clara, and Kern Counties. It offers checking and savings accounts, deposits, mortgage loans, credit and debit cards, safe deposit boxes, automated teller machines, wire transfers, money market accounts, mobile banking, and wealth management services. The company's primary sources of revenue are interest income from loans and investment securities.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.